CVS Health Co. (NYSE:CVS) Shares Sold by Missouri Trust & Investment Co

Missouri Trust & Investment Co lowered its position in shares of CVS Health Co. (NYSE:CVS) by 18.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,944 shares of the pharmacy operator’s stock after selling 5,129 shares during the period. Missouri Trust & Investment Co’s holdings in CVS Health were worth $985,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. MidAtlantic Capital Management Inc. purchased a new position in shares of CVS Health in the 3rd quarter valued at about $25,000. Ridgewood Investments LLC increased its stake in CVS Health by 255.7% in the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 450 shares during the last quarter. Livelsberger Financial Advisory acquired a new stake in CVS Health during the third quarter worth approximately $31,000. Legacy Investment Solutions LLC purchased a new stake in shares of CVS Health during the 3rd quarter worth approximately $31,000. Finally, Reston Wealth Management LLC purchased a new position in shares of CVS Health in the 3rd quarter valued at $32,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Stock Performance

Shares of CVS opened at $53.14 on Wednesday. The company has a market capitalization of $66.87 billion, a PE ratio of 13.49, a P/E/G ratio of 0.79 and a beta of 0.59. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $80.75. The company has a 50-day simple moving average of $51.27 and a 200-day simple moving average of $56.29. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. The company had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The company’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same period last year, the firm earned $2.21 EPS. Equities research analysts predict that CVS Health Co. will post 5.22 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be given a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 5.01%. The ex-dividend date of this dividend is Thursday, January 23rd. CVS Health’s dividend payout ratio is currently 67.51%.

Wall Street Analyst Weigh In

CVS has been the subject of a number of research reports. Deutsche Bank Aktiengesellschaft raised shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price target for the company in a research report on Tuesday, December 3rd. Cantor Fitzgerald reissued a “neutral” rating and issued a $62.00 target price on shares of CVS Health in a research report on Tuesday, October 1st. Truist Financial cut their price target on CVS Health from $67.00 to $60.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Wells Fargo & Company raised CVS Health from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $60.00 to $66.00 in a report on Monday, November 18th. Finally, Barclays reduced their price target on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating for the company in a research report on Thursday, November 7th. One analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $68.71.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.